We have located links that may give you full text access.
Analysis of the reasons for transfers between hemodialysis and peritoneal dialysis and their effect on survivals.
Data on the outcomes of patients who are transferred between hemodialysis (HD) and peritoneal dialysis (PD) are scant. This study analyzes data on patients transferred from their initial modality at the University Hospital Gent between 1978 and 1996 for the reasons for, and outcomes from, the transfer. The reasons for the transfer from HD to PD (n = 35) were access problems (25%), cardiovascular (40%) and blood pressure problems (25%), and personal choice (10%). For the transfer from PD to HD (n = 32) peritonitis (50%), social problems (14%), adequacy or ultrafiltration problems (25%), and leakage (11%) were the reasons. There were no differences in survivals between patients who started on HD and who were transferred to PD, and those who remained on HD (P = 0.4). There were improved survivals for the patients who started on PD and who were transferred to HD compared to those remaining on PD (P = 0.01). It is concluded that transferring problematic HD patients to PD does not improve their survivals, whereas the survival of patients with PD-related complications is improved by transferring them to HD. This is due to the differences in the reasons for transfer, which are PD-related complications in the case of PD patients, and cardiovascular problems in the case of HD patients.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app